Epirubicin-induced primary Sjögren's syndrome.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D001943:Breast Neoplasms; D004317:Doxorubicin / Q000009:adverse effects*; D015251:Epirubicin; D005260:Female; D006801:Humans; D008875:Middle Aged; D012859:Sjogren's Syndrome / Q000139:chemically induced*
D015251:Epirubicin; D004317:Doxorubicin